390 related articles for article (PubMed ID: 11313879)
21. The role of regulated phosphorylation in the biological activity of transcription factors SRF and Elk-1/SAP-1.
Papavassiliou AG
Anticancer Res; 1994; 14(5A):1923-6. PubMed ID: 7847828
[TBL] [Abstract][Full Text] [Related]
22. CSF-1 induces fos gene transcription and activates the transcription factor Elk-1 in mature osteoclasts.
Yao GQ; Itokawa T; Paliwal I; Insogna K
Calcif Tissue Int; 2005 May; 76(5):371-8. PubMed ID: 15812575
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
[TBL] [Abstract][Full Text] [Related]
24. The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light.
Price MA; Cruzalegui FH; Treisman R
EMBO J; 1996 Dec; 15(23):6552-63. PubMed ID: 8978682
[TBL] [Abstract][Full Text] [Related]
25. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
Maira SM; Wurtz JM; Wasylyk B
EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
[TBL] [Abstract][Full Text] [Related]
26. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
27. Activation of the c-fos SRE through SAP-1a.
Masutani H; Magnaghi-Jaulin L; Ait-Si-Ali S; Groisman R; Robin P; Harel-Bellan A
Oncogene; 1997 Oct; 15(14):1661-9. PubMed ID: 9349499
[TBL] [Abstract][Full Text] [Related]
28. WDR26: a novel Gbeta-like protein, suppresses MAPK signaling pathway.
Zhu Y; Wang Y; Xia C; Li D; Li Y; Zeng W; Yuan W; Liu H; Zhu C; Wu X; Liu M
J Cell Biochem; 2004 Oct; 93(3):579-87. PubMed ID: 15378603
[TBL] [Abstract][Full Text] [Related]
29. Signal transduction and the Ets family of transcription factors.
Yordy JS; Muise-Helmericks RC
Oncogene; 2000 Dec; 19(55):6503-13. PubMed ID: 11175366
[TBL] [Abstract][Full Text] [Related]
30. Kinetic analysis of RSK2 and Elk-1 interaction on the serum response element and implications for cellular engineering.
Aksan Kurnaz I
Biotechnol Bioeng; 2004 Dec; 88(7):890-900. PubMed ID: 15515167
[TBL] [Abstract][Full Text] [Related]
31. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
32. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
[TBL] [Abstract][Full Text] [Related]
33. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP.
Janknecht R; Nordheim A
Biochem Biophys Res Commun; 1996 Nov; 228(3):831-7. PubMed ID: 8941362
[TBL] [Abstract][Full Text] [Related]
34. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
[TBL] [Abstract][Full Text] [Related]
35. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a postreceptor signaling defect that impairs cfos expression in cultured fibroblasts of a patient with insulin resistance.
Knebel B; Kotzka J; Avci H; Schiller M; Brüning JC; Hafner M; Krone W; Müller-Wieland D
Biochem Biophys Res Commun; 2000 Feb; 268(2):577-82. PubMed ID: 10679246
[TBL] [Abstract][Full Text] [Related]
37. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b.
Cui JQ; Wang H; Reddy ES; Rao VN
Oncol Rep; 1998; 5(3):585-9. PubMed ID: 9538156
[TBL] [Abstract][Full Text] [Related]
38. elk-1 domains responsible for autonomous DNA binding, SRE:SRF interaction and negative regulation of DNA binding.
Rao VN; Reddy ES
Oncogene; 1992 Nov; 7(11):2335-40. PubMed ID: 1437156
[TBL] [Abstract][Full Text] [Related]
39. The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity.
Wang LH; Yang XY; Zhang X; Mihalic K; Xiao W; Farrar WL
Cancer Res; 2003 May; 63(9):2046-51. PubMed ID: 12727818
[TBL] [Abstract][Full Text] [Related]
40. Dark pulse suppression of P-ERK and c-Fos in the hamster suprachiasmatic nuclei.
Coogan AN; Piggins HD
Eur J Neurosci; 2005 Jul; 22(1):158-68. PubMed ID: 16029205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
